3D Tissue Models

Hepatology: Wyeth BioPharma

Total Score People Score Events Score
7 7 6
Date Event Presentation Speakers
June 27, 2011 RNAi, miRNA & siRNA Second Chair's Opening Remarks Attila A. Seyhan
Second Chair’s Closing Remarks and Close of Day One Attila A. Seyhan
RNA interference as a research and therapeutic tool…Has its time come? Attila A. Seyhan
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Designing, Simulating, and Executing an Adaptive Trial Vladimir Dragalin
Adaptive Designs as a Roadmap to Personalized Medicine Michael Krams
August 3, 2009 The Next Wave of Antibody Therapeutics Targeting B-Cell Lymphomas with Inotuzumab Ozogamicin (CMC-544), an Anti-CD22 Immunoconjugate Erik R. Vandendries
March 25, 2008 Mastering Medicinal Chemistry SAR in the Area of Antibody-Targeted Chemotherapy: Philip R Hamann
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 13: (Part One) Development of Novel Drug Delivery Systems (Part Two) Combinatorial Chemistry & High Throughput Screening (09:00-12:00) Xiaoke Yang
Session 13: (Part One): Binding Characterization of the IL-13 Signaling Complex and Development of a Ternary TR-FRET Assay (10:20-10:40) Xiaoke Yang
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: PHARMACOGENETICS: The Role of Pharmacogenomics in Discovery Translational Medicine: From Target Validation to Patient Selection (08:35-09:05) Giora Feuerstein
Third annual Genomic Biomarkers: PHARMACOGENETICS (08:30-11:30) Giora Feuerstein
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.